Compare FirstEnergy Corp. (FE) vs Summit Therapeutics Inc (SMMT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FirstEnergy Corp. vs Summit Therapeutics Inc — how do they compare? FirstEnergy Corp. trades at $46.95 (market cap $27.10B), while Summit Therapeutics Inc trades at $15.42 (market cap $12.06B). The key difference: FirstEnergy Corp. is far larger — about 2.2× Summit Therapeutics Inc's market cap, and FirstEnergy Corp. pays a 3.97% dividend while Summit Therapeutics Inc pays none. Which is the better fit depends on your goals.
| FE | SMMT | |
|---|---|---|
Market Cap | $27.10B | $12.06B |
Sector | Utilities | Health |
52-Week High | $51.91 | $26.98 |
52-Week Low | $42.83 | $12.55 |
Enterprise Value | $56.02B | $11.39B |
Dividend Yield | 3.97% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FirstEnergy (FE) trades at $46.76, down 1.5% with bearish technical signals despite recent earnings beat. The utility shows steady revenue growth to $15.09B (2025) and maintains a 6.86% net margin, though EPS performance has been mixed. Analyst consensus is divided with 12 Buy and 16 Hold ratings, targeting $52.67 average price. Recent news highlights institutional buying and grid investments to support rising data center demand.
Investment outlook balances growth from infrastructure spending and data center demand against execution risks and debt levels. The stock offers value below analyst targets with dividend income, but faces headwinds from capital expenditure requirements and interest rate sensitivity. Current valuation at P/E 25.05 appears reasonable for sector growth prospects.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FirstEnergy Corp.
FirstEnergy is one of the largest investor-owned utilities in the United States with 10 regulated distribution companies across six mid-Atlantic and Midwestern states. FirstEnergy also owns and operates one of the nation's largest electric transmission systems with 24,000 miles of lines.
Read more on FE →About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →
